VIVOLTA expands facility to scale electrospun medical implants manufacturing
Eindhoven, Netherlands, November 3, 2025 — Medical-device CDMO VIVOLTA has signed a long-term agreement for a dedicated production facility...
CDMO
Advertisement
Ritedose Expands U.S. Nebulized Drug Portfolio with FDA Approval
COLUMBIA, S.C., October 30, 2025 — The Ritedose Corporation has received U.S. Food and Drug Administration (FDA) approval to...
BioHarvest Sciences and Saffron Tech Forge Strategic CDMO Partnership to Revolutionize Botanical Synthesis
Vancouver, British Columbia & Rehovot, Israel — October 30, 2025 — BioHarvest Sciences Inc. (NASDAQ: BHST) has announced a...
Wheeler Bio and MindImmune Partner on Alzheimer’s Therapy MITI-101
OKLAHOMA CITY, Sept. 17, 2025 – Wheeler Bio, Inc., a U.S.-based contract development and manufacturing organization (CDMO), announced today...
Andelyn Biosciences Partners with Tern Therapeutics for Late-Stage Manufacturing of AAV Gene Therapy for CLN2 Batten Disease
Andelyn Biosciences, a leading cell and gene therapy CDMO, has partnered with Tern Therapeutics to perform late-stage Process Performance...
Advertisement
